137 related articles for article (PubMed ID: 16619191)
1. Interaction of radiolabeled antibodies with fungal cells and components of the immune system in vitro and during radioimmunotherapy for experimental fungal infection.
Dadachova E; Bryan RA; Apostolidis C; Morgenstern A; Zhang T; Moadel T; Torres M; Huang X; Revskaya E; Casadevall A
J Infect Dis; 2006 May; 193(10):1427-36. PubMed ID: 16619191
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of the human pathogenic fungi Cryptococcus neoformans and Histoplasma capsulatum to gamma-radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes.
Dadachova E; Howell RW; Bryan RA; Frenkel A; Nosanchuk JD; Casadevall A
J Nucl Med; 2004 Feb; 45(2):313-20. PubMed ID: 14960655
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of capsular polysaccharide-specific IgM and IgG antibodies and F(ab')2 and Fab fragments as delivery vehicles for radioimmunotherapy of fungal infection.
Dadachova E; Bryan RA; Huang X; Ortiz G; Moadel T; Casadevall A
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5629s-5635s. PubMed ID: 17875799
[TBL] [Abstract][Full Text] [Related]
4. Treatment of infection with radiolabeled antibodies.
Dadachova E; Casadevall A
Q J Nucl Med Mol Imaging; 2006 Sep; 50(3):193-204. PubMed ID: 16868533
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunotherapy of micrometastases in lung with vascular targeted 213Bi.
Kennel SJ; Boll R; Stabin M; Schuller HM; Mirzadeh S
Br J Cancer; 1999 Apr; 80(1-2):175-84. PubMed ID: 10389994
[TBL] [Abstract][Full Text] [Related]
6. Radioimmunotherapy of experimental human metastatic melanoma with melanin-binding antibodies and in combination with dacarbazine.
Revskaya E; Jongco AM; Sellers RS; Howell RC; Koba W; Guimaraes AJ; Nosanchuk JD; Casadevall A; Dadachova E
Clin Cancer Res; 2009 Apr; 15(7):2373-9. PubMed ID: 19293257
[TBL] [Abstract][Full Text] [Related]
7. Toward developing a universal treatment for fungal disease using radioimmunotherapy targeting common fungal antigens.
Bryan RA; Guimaraes AJ; Hopcraft S; Jiang Z; Bonilla K; Morgenstern A; Bruchertseifer F; Del Poeta M; Torosantucci A; Cassone A; Nosanchuk JD; Casadevall A; Dadachova E
Mycopathologia; 2012 Jun; 173(5-6):463-71. PubMed ID: 22048869
[TBL] [Abstract][Full Text] [Related]
8. Treatment of early and established Cryptococcus neoformans infection with radiolabeled antibodies in immunocompetent mice.
Jiang Z; Bryan RA; Morgenstern A; Bruchertseifer F; Casadevall A; Dadachova E
Antimicrob Agents Chemother; 2012 Jan; 56(1):552-4. PubMed ID: 22005995
[TBL] [Abstract][Full Text] [Related]
9. Computational model predicts effective delivery of 188-Re-labeled melanin-binding antibody to metastatic melanoma tumors with wide range of melanin concentrations.
Schweitzer AD; Rakesh V; Revskaya E; Datta A; Casadevall A; Dadachova E
Melanoma Res; 2007 Oct; 17(5):291-303. PubMed ID: 17885584
[TBL] [Abstract][Full Text] [Related]
10. An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer.
McDevitt MR; Barendswaard E; Ma D; Lai L; Curcio MJ; Sgouros G; Ballangrud AM; Yang WH; Finn RD; Pellegrini V; Geerlings MW; Lee M; Brechbiel MW; Bander NH; Cordon-Cardo C; Scheinberg DA
Cancer Res; 2000 Nov; 60(21):6095-100. PubMed ID: 11085533
[TBL] [Abstract][Full Text] [Related]
11. Preclinical testing of radiopharmaceuticals for novel applications in HIV, bacterial and fungal infectious diseases.
Shah M; Garg G; Dadachova E
Q J Nucl Med Mol Imaging; 2015 Sep; 59(3):317-26. PubMed ID: 26200222
[TBL] [Abstract][Full Text] [Related]
12. Effects of radiation type and delivery mode on a radioresistant eukaryote Cryptococcus neoformans.
Shuryak I; Bryan RA; Broitman J; Marino SA; Morgenstern A; Apostolidis C; Dadachova E
Nucl Med Biol; 2015 Jun; 42(6):515-23. PubMed ID: 25800676
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunotherapy of solid tumors targeting a cell-surface protein, FZD10: therapeutic efficacy largely depends on radiosensitivity.
Hanaoka H; Katagiri T; Fukukawa C; Yoshioka H; Yamamoto S; Iida Y; Higuchi T; Oriuchi N; Paudyal B; Paudyal P; Nakamura Y; Endo K
Ann Nucl Med; 2009 Jul; 23(5):479-85. PubMed ID: 19412654
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunotherapy of Cryptococcus neoformans spares bystander mammalian cells.
Bryan RA; Jiang Z; Morgenstern A; Bruchertseifer F; Casadevall A; Dadachova E
Future Microbiol; 2013 Sep; 8(9):1081-9. PubMed ID: 24020737
[TBL] [Abstract][Full Text] [Related]
15. Validation of 213Bi-alpha radioimmunotherapy for multiple myeloma.
Couturier O; Faivre-Chauvet A; Filippovich IV; Thédrez P; Saï-Maurel C; Bardiès M; Mishra AK; Gauvrit M; Blain G; Apostolidis C; Molinet R; Abbe JC; Bataille R; Wijdenes J; Chatal JF; Chérel M
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3165s-3170s. PubMed ID: 10541359
[TBL] [Abstract][Full Text] [Related]
16. Locoreginal radioimmunotherapy with 186Re-labeled monoclonal antibody in treating small peritoneal carcinomatosis of colon cancer in mice in comparison with 131I-counterpart.
Kinuya S; Yokoyama K; Izumo M; Sorita T; Obata T; Mori H; Shiba K; Watanabe N; Shuke N; Michigishi T; Tonami N
Cancer Lett; 2005 Feb; 219(1):41-8. PubMed ID: 15694663
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
Tijink BM; Neri D; Leemans CR; Budde M; Dinkelborg LM; Stigter-van Walsum M; Zardi L; van Dongen GA
J Nucl Med; 2006 Jul; 47(7):1127-35. PubMed ID: 16818947
[TBL] [Abstract][Full Text] [Related]
18. Antibody-guided alpha radiation effectively damages fungal biofilms.
Martinez LR; Bryan RA; Apostolidis C; Morgenstern A; Casadevall A; Dadachova E
Antimicrob Agents Chemother; 2006 Jun; 50(6):2132-6. PubMed ID: 16723575
[TBL] [Abstract][Full Text] [Related]
19. Beta emitters rhenium-188 and lutetium-177 are equally effective in radioimmunotherapy of HPV-positive experimental cervical cancer.
Phaeton R; Jiang Z; Revskaya E; Fisher DR; Goldberg GL; Dadachova E
Cancer Med; 2016 Jan; 5(1):9-16. PubMed ID: 26625938
[TBL] [Abstract][Full Text] [Related]
20. In vitro targeting of NG2 antigen by 213Bi-9.2.27 alpha-immunoconjugate induces cytotoxicity in human uveal melanoma cells.
Li Y; Wang J; Rizvi SM; Jager MJ; Conway RM; Billson FA; Allen BJ; Madigan MC
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4365-71. PubMed ID: 16303921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
